Depending on the promoters, genetic background and expression levels, IL-15 mice show either altered immunity or development of aggressive T-/NK- cell leukemia, and cutaneous T-cell lymphoma (13, 28–32). The gene discussed is IL15; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.